HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$40.24
Day range
$39.40 - $41.09
Year range
$18.92 - $81.73
Market cap
4.52B USD
Avg Volume
4.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 74.57M | 118.99% |
Net income | -65.56M | -194.66% |
Net profit margin | — | — |
Earnings per share | -0.58 | -190.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 807.72M | -14.28% |
Total assets | 827.85M | -12.57% |
Total liabilities | 32.39M | 25.26% |
Total equity | 795.46M | — |
Shares outstanding | 112.44M | — |
Price to book | 5.68 | — |
Return on assets | -22.00% | — |
Return on capital | -22.68% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -65.56M | -194.66% |
Cash from operations | -47.06M | -65.05% |
Cash from investing | 42.51M | 133.72% |
Cash from financing | 507.00K | -82.55% |
Net change in cash | -4.06M | 97.32% |
Free cash flow | -25.63M | -17.00% |
About
CEO
Founded
2012
Website
Employees
49
